Embed presentation
Downloaded 17 times





















- HER2+ breast cancer accounts for 20-30% of breast cancers and is characterized by overexpression of the HER2 receptor tyrosine kinase. HER2 overexpression leads to constant activation of downstream signaling pathways like MAPK and PI3K/AKT, promoting cell growth and inhibiting apoptosis. Diagnosis involves tests like mammography, biopsy for HER2 status, and imaging for metastasis. Treatment targets HER2 signaling pathways.




















